|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,360 KRW | -0.94% |
|
+1.52% | -4.54% |
Sinil Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 162.09 million compared to KRW 151.74 million a year ago. Net income was KRW 3,662.53 million compared to KRW 3,798.64 million a year ago.
Basic earnings per share from continuing operations was KRW 317 compared to KRW 329 a year ago. Basic earnings per share was KRW 317 compared to KRW 329 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.54% | 60.76M | |
| +20.76% | 43.77B | |
| +28.00% | 22.83B | |
| +20.25% | 15.56B | |
| +18.82% | 14.34B | |
| +55.83% | 12.96B | |
| -0.05% | 6.79B | |
| -12.70% | 6.41B | |
| -8.87% | 5.73B | |
| +14.65% | 5.69B |
SINIL PHARMACEUTICAL CO., LTD. 
